Literature DB >> 15655365

Revisiting the "Cdk-centric" view of the mammalian cell cycle.

Marcos Malumbres1.   

Abstract

Since the early genetic studies in yeast, regulation of the cell cycle has been associated with the sequential activation of several proline-directed serine-threonine protein kinases by cyclins. From yeast to humans, the activity of these cyclin-dependent kinases (Cdks) have been thought to be essential for cell cycle regulation. Recent gene-targeted mouse models for different cyclins and Cdks have shown that members of these families show a certain level of redundancy and that specific complexes are not required for the mitotic cell cycle. However, the complexity of the Cdk-cyclin network and the promiscuity of their members makes it difficult to understand the relative contribution of these proteins to the mammalian cell division cycle. Compensatory roles by non-Cdk activities and Cdk-independent functions of cyclins are increasing the complexity of the current simplistic models. We still do not know whether at least one cyclin-dependent kinase activity is required for cell cycle progression in mammalian cells. Indeed, this is a relevant question for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655365     DOI: 10.4161/cc.4.2.1406

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

Review 1.  Therapeutic opportunities to control tumor cell cycles.

Authors:  Marcos Malumbres
Journal:  Clin Transl Oncol       Date:  2006-06       Impact factor: 3.405

2.  Cell cycle regulators in the control of metabolism.

Authors:  Emilie Blanchet; Jean-Sébastien Annicotte; Lluis Fajas
Journal:  Cell Cycle       Date:  2009-12-17       Impact factor: 4.534

3.  CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.

Authors:  Derek P DiRocco; John Bisi; Patrick Roberts; Jay Strum; Kwok-Kin Wong; Norman Sharpless; Benjamin D Humphreys
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

4.  Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.

Authors:  Søren M Johnson; Chad D Torrice; Jessica F Bell; Kimberly B Monahan; Qi Jiang; Yong Wang; Matthew R Ramsey; Jian Jin; Kwok-Kin Wong; Lishan Su; Daohong Zhou; Norman E Sharpless
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

Review 5.  Novel HIV-1 therapeutics through targeting altered host cell pathways.

Authors:  William Coley; Kylene Kehn-Hall; Rachel Van Duyne; Fatah Kashanchi
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

6.  An overview of Cdk1-controlled targets and processes.

Authors:  Jorrit M Enserink; Richard D Kolodner
Journal:  Cell Div       Date:  2010-05-13       Impact factor: 5.130

7.  Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.

Authors:  Utsav H Saxena; Christina M H Powell; Jill K Fecko; Roxanne Cacioppo; Hubert S Chou; Geoffrey M Cooper; Ulla Hansen
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

8.  The molecular genetics of breast cancer and targeted therapy.

Authors:  Rachel Suter; James A Marcum
Journal:  Biologics       Date:  2007-09

9.  Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis.

Authors:  Kyung Uk Hong; Yong-Bock Choi; Jung-Hwa Lee; Hyun-Jun Kim; Hye-Rim Kwon; Yeon-Sun Seong; Heung Tae Kim; Joobae Park; Chang-Dae Bae; Kyeong-Man Hong
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

10.  Cdc28/Cdk1 positively and negatively affects genome stability in S. cerevisiae.

Authors:  Jorrit M Enserink; Hans Hombauer; Meng-Er Huang; Richard D Kolodner
Journal:  J Cell Biol       Date:  2009-04-27       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.